~16 Percent of COVID Cases Develop Postacute Sequelae of SARS-CoV-2
Most Speakers at FDA Advisory Committee Meetings Support Drug Approval
Countries Involved in U.S. Clinical Trials Do Not Gain Timely Access to Approved Medicines
FDA Now Providing Daily Updates on Adverse Events
Guidelines Updated for Short-Course Radiation for Localized Prostate Cancer
Air Pollution Exposure Tied to Atopic Dermatitis in Children
Guidelines Updated for Prostate Cancer Screening
Lowering Doses of Maternal OUD Meds Not Linked to Severity of Neonatal Opioid Withdrawal